Chang Wen-Shin, Shen Te-Chun, Liao Jiuan-Miaw, Tsai Yueh-Ting, Hsia Te-Chun, Wu Hsi-Chin, Tsai Chia-Wen, Bau Da-Tian
Terry Fox Cancer Research Laboratory, Translational Medicine Research Center, China Medical University Hospital, Taichung, Taiwan.
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.
Onco Targets Ther. 2020 Feb 20;13:1583-1591. doi: 10.2147/OTT.S231733. eCollection 2020.
DNA repair systems play essential roles in genomic stability and carcinogenesis. Therefore, genotypes at DNA repair loci may contribute to the determination of personal susceptibility to cancers. The contribution of () genotypes to renal cell carcinoma (RCC) is largely unknown. This study aimed to evaluate the contributions of rs1052133 genotypes to the RCC risk.
We evaluated the contribution of rs1052133 (G/C) genotypes among 118 cases and 590 controls and analyzed the interactions of genotypes with smoking, alcohol drinking, hypertension, and diabetes status.
The rs1052133 CC genotype was significantly associated with a decreased RCC risk compared with that of the GG genotype (odds ratio [OR] = 0.25, 95% confidence interval [CI] = 0.09-0.72, = 0.0049). The frequency of the rs1052133 C allele was significantly low in the RCC group (22.5% vs 31.2%; OR = 0.64; 95% CI = 0.46-0.89, = 0.0074). Stratifying the analysis according to smoking, alcohol drinking, and diabetes status revealed no difference in the rs1052133 genotype distribution among these subgroups. A significant differential distribution of rs1052133 genotypes was observed among subjects with hypertension.
The CC genotype of rs1052133 may play a role in determining RCC susceptibility among Taiwanese people and may serve as a biomarker of RCC, particularly in patients with hypertension.
DNA修复系统在基因组稳定性和致癌过程中起着至关重要的作用。因此,DNA修复基因座的基因型可能有助于确定个体对癌症的易感性。()基因型对肾细胞癌(RCC)的影响在很大程度上尚不清楚。本研究旨在评估rs1052133基因型对RCC风险的影响。
我们评估了118例病例和590例对照中rs1052133(G/C)基因型的影响,并分析了该基因型与吸烟、饮酒、高血压和糖尿病状况之间的相互作用。
与GG基因型相比,rs1052133 CC基因型与RCC风险降低显著相关(优势比[OR]=0.25,95%置信区间[CI]=0.09 - 0.72,P = 0.0049)。RCC组中rs1052133 C等位基因的频率显著较低(22.5%对31.2%;OR = 0.64;95% CI = 0.46 - 0.89,P = 0.0074)。根据吸烟、饮酒和糖尿病状况进行分层分析,发现这些亚组中rs1052133基因型分布没有差异。在高血压患者中观察到rs1052133基因型存在显著的差异分布。
rs1052133的CC基因型可能在台湾人群RCC易感性的决定中起作用,并可能作为RCC的生物标志物,特别是在高血压患者中。